Medicare Enrolled
Dr. David Packey, M.D. PH.D
Neurology · Melbourne, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Packey from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Packey?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Packey
Dr. David Packey is a neurology specialist in Melbourne, FL, with 21 years of NPI registration. Based on federal Medicare data, Dr. Packey performed 52,136 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Packey received a total of $10,604 from 61 pharmaceutical and/or device companies across 608 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Packey is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 1% volume in FL
$10,604 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 66496 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗52,136
Medicare services
Top 1% in FL for neurology
Not available
Unique patients (not deduplicated)
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
49,732 | $5 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,140 | $91 | $200 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
177 | $70 | $180 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
173 | $56 | $125 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
136 | $123 | $300 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
133 | $117 | $300 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 99 | $58 | $100 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
94 | $132 | $300 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
66 | $133 | $375 |
| Chemical nerve block for neck muscles Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box. |
55 | $107 | $260 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
49 | $94 | $200 |
| Chemical nerve block injection, 5+ arm/leg muscles Injection of a chemical agent to paralyze five or more muscles in the first extremity treated. |
39 | $140 | $350 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
39 | $156 | $450 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
31 | $220 | $600 |
| New patient office visit, complex (60-74 min) | 29 | $155 | $400 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
26 | $137 | $375 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
25 | $288 | $700 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
25 | $99 | $300 |
| MRI scan of brain, without contrast A magnetic resonance imaging test of the brain that does not use contrast dye. This procedure creates detailed images of the brain's structure using magnetic fields and radio waves. |
22 | $56 | $180 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
18 | $59 | $150 |
| Nerve conduction study, 3-4 tests A diagnostic test that measures how well nerves send electrical signals. It involves performing 3 to 4 separate nerve conduction studies to evaluate nerve function. |
17 | $86 | $250 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
11 | $40 | $100 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$10,604
Total received (2018-2024)
Avg $1,515/year across 7 years
Top 27% in FL for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
608
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,580
2023
$1,674
2022
$1,209
2021
$1,638
2020
$990
2019
$1,922
2018
$1,591
Payments by company (2024)
PFIZER INC.
$291
Alexion Pharmaceuticals, Inc.
$209
ABBVIE INC.
$175
UCB, Inc.
$142
Eisai Inc.
$141
ARGENX US, INC.
$140
Neurelis, Inc.
$93
SCILEX PHARMACEUTICALS INC.
$72
Novartis Pharmaceuticals Corporation
$57
Otsuka America Pharmaceutical, Inc.
$46
Teva Pharmaceuticals USA, Inc.
$32
Averitas Pharma Inc.
$29
SK Life Science, Inc.
$28
TG Therapeutics, Inc.
$23
ACADIA Pharmaceuticals Inc
$23
Biogen, Inc.
$21
Azurity Pharmaceuticals, Inc.
$21
Merz Pharmaceuticals, LLC
$21
BioMarin Pharmaceutical Inc.
$16
Top 3 companies account for 42.8% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$948
UCB, Inc.
$768
Novartis Pharmaceuticals Corporation
$626
Biogen, Inc.
$578
ABBVIE INC.
$527
GENZYME CORPORATION
$458
Amgen Inc.
$455
Alexion Pharmaceuticals, Inc.
$405
PFIZER INC.
$403
EMD Serono, Inc.
$375
Eisai Inc.
$333
ARGENX US, INC.
$266
Biohaven Pharmaceuticals, Inc.
$260
AbbVie Inc.
$257
Sunovion Pharmaceuticals Inc.
$235
Neurelis, Inc.
$230
SK Life Science, Inc.
$221
NOVARTIS PHARMACEUTICALS CORPORATION
$195
Lilly USA, LLC
$193
Allergan Inc.
$192
EISAI INC.
$191
Acorda Therapeutics, Inc
$180
Kyowa Kirin, Inc.
$166
ACADIA Pharmaceuticals Inc
$160
Biohaven Pharmaceutical Holding Company Ltd.
$144
Neurocrine Biosciences, Inc.
$143
Genentech USA, Inc.
$124
Allergan, Inc.
$107
Lundbeck LLC
$103
Sumitomo Pharma America, Inc.
$102
Otsuka America Pharmaceutical, Inc.
$100
US WorldMeds, LLC
$95
CSL Behring
$84
Avanir Pharmaceuticals, Inc.
$81
SCILEX PHARMACEUTICALS INC.
$72
Celgene Corporation
$68
Adamas Pharmaceuticals, Inc.
$65
Ipsen Biopharmaceuticals, Inc
$58
Amneal Pharmaceuticals LLC
$57
LivaNova USA, Inc.
$54
Mallinckrodt Enterprises LLC
$45
JAZZ PHARMACEUTICALS INC.
$42
Corium, LLC
$42
Takeda Pharmaceuticals U.S.A., Inc.
$40
Greenwich Biosciences, Inc.
$31
Averitas Pharma Inc.
$29
Harmony Biosciences LLC
$27
Grifols USA, LLC
$27
Supernus Pharmaceuticals, Inc.
$24
TG Therapeutics, Inc.
$23
Alnylam Pharmaceuticals Inc.
$22
Janssen Pharmaceuticals, Inc
$22
Azurity Pharmaceuticals, Inc.
$21
Merz Pharmaceuticals, LLC
$21
MITSUBISHI TANABE PHARMA AMERICA, INC.
$18
Mallinckrodt LLC
$18
Impax Laboratories, Inc.
$16
BioMarin Pharmaceutical Inc.
$16
Merz North America, Inc.
$15
Mallinckrodt Hospital Products Inc.
$13
GRT US Holding, Inc.
$12
Top 3 companies account for 22.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADLARITY · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · Azstarys · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Brineura · Briviact · COMIRNATY · COPAXONE · DUOPA · Dysport · EMGALITY · EPIDIOLEX · Epidiolex · Fycompa · GILENYA · GOCOVRI · Gamunex-C · HORIZANT · Hizentra · INBRIJA · INGREZZA · KESIMPTA · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · OCREVUS · ONFI · ONPATTRO · Privigen · QELBREE · QULIPTA · QUTENZA · Qutenza · RADICAVA · REXULTI · RYTARY · Rebif · SOLIRIS · SPINRAZA · Soliris · TECFIDERA · TRINTELLIX · TYSABRI · UBRELVY · ULTOMIRIS · VALTOCO · VNS Therapy · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · Wakix · XEOMIN · Xadago · Xeomin · ZEPOSIA · ZTLido
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
30
County median income
$75,817
Nearest hospital to ZIP centroid (approximate)
HOLMES REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Packey is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Packey experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Packey performed 49,732 botox injection, per unit services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Packey receive payments from pharmaceutical companies?
Yes. Dr. Packey received a total of $10,604 from 61 companies across 608 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Packey's costs compare to other neurologists in Melbourne?
Dr. Packey's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Packey) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Melbourne
Browse neurologists in Melbourne ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in FL
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in FL
Which FL neurologists receive the most from drug and device companies.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology